These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 27383016)

  • 21. Epithelial Protein Lost in Neoplasm, EPLIN, the Cellular and Molecular Prospects in Cancers.
    Zeng J; Jiang WG; Sanders AJ
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs regulate the epithelial to mesenchymal transition (EMT) in cancer progression.
    Hu Y; Tang H
    Microrna; 2014; 3(2):108-17. PubMed ID: 25323025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of VEGF-A signalling in development, regeneration, and tumours.
    Matsumoto K; Ema M
    J Biochem; 2014 Jul; 156(1):1-10. PubMed ID: 24839295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Microenvironment of Lung Cancer and Therapeutic Implications.
    Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
    Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [FGF/FGFR signalling: Implication in oncogenesis and perspectives].
    Flippot R; Kone M; Magné N; Vignot S
    Bull Cancer; 2015 Jun; 102(6):516-26. PubMed ID: 25986739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.
    Liu X; Fan D
    Curr Pharm Des; 2015; 21(10):1279-91. PubMed ID: 25506898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of angiotensin II type 1 receptor in breast cancer cells induces epithelial-mesenchymal transition and promotes tumor growth and angiogenesis.
    Oh E; Kim JY; Cho Y; An H; Lee N; Jo H; Ban C; Seo JH
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1071-81. PubMed ID: 26975580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis.
    Caccuri F; Ronca R; Laimbacher AS; Berenzi A; Steimberg N; Campilongo F; Mazzuca P; Giacomini A; Mazzoleni G; Benetti A; Caselli E; Presta M; Di Luca D; Fraefel C; Caruso A
    Oncotarget; 2017 Jul; 8(27):44533-44549. PubMed ID: 28562350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The epithelial-mesenchymal transition in cancer: a potential critical topic for translational proteomic research.
    Bottoni P; Isgrò MA; Scatena R
    Expert Rev Proteomics; 2016; 13(1):115-33. PubMed ID: 26567562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroblast growth factor receptors: multifactorial-contributors to tumor initiation and progression.
    Feng S; Zhou L; Nice EC; Huang C
    Histol Histopathol; 2015 Jan; 30(1):13-31. PubMed ID: 25053532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of Signaling Pathways in the Epithelial-Mesenchymal Transition in Cancer.
    Liu X; Yun F; Shi L; Li ZH; Luo NR; Jia YF
    Asian Pac J Cancer Prev; 2015; 16(15):6201-6. PubMed ID: 26434817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2-mediated pathway in breast cancer.
    Balakrishnan S; Bhat FA; Raja Singh P; Mukherjee S; Elumalai P; Das S; Patra CR; Arunakaran J
    Cell Prolif; 2016 Dec; 49(6):678-697. PubMed ID: 27641938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling Proteolytically Driven Tumor Lymphangiogenesis.
    Lolas G; Jensen L; Bourantas GC; Tsikourkitoudi V; Syrigos K
    Adv Exp Med Biol; 2016; 936():107-136. PubMed ID: 27739045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
    Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mast cell contribution to angiogenesis related to tumour progression.
    Ribatti D; Crivellato E; Roccaro AM; Ria R; Vacca A
    Clin Exp Allergy; 2004 Nov; 34(11):1660-4. PubMed ID: 15544587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EMT Transition States during Tumor Progression and Metastasis.
    Pastushenko I; Blanpain C
    Trends Cell Biol; 2019 Mar; 29(3):212-226. PubMed ID: 30594349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Six family of homeobox genes and related mechanisms in tumorigenesis protocols.
    Armat M; Ramezani F; Molavi O; Sabzichi M; Samadi N
    Tumori; 2016 Jun; 2016(3):236-43. PubMed ID: 27056337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FGF18 Enhances Migration and the Epithelial-Mesenchymal Transition in Breast Cancer by Regulating Akt/GSK3β/Β-Catenin Signaling.
    Song N; Zhong J; Hu Q; Gu T; Yang B; Zhang J; Yu J; Ma X; Chen Q; Qi J; Liu Y; Su W; Feng Z; Wang X; Wang H
    Cell Physiol Biochem; 2018; 49(3):1019-1032. PubMed ID: 30196303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The non-canonical role of vascular endothelial growth factor-C axis in cancer progression.
    Wang CA; Tsai SJ
    Exp Biol Med (Maywood); 2015 Jun; 240(6):718-24. PubMed ID: 25888649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced research on vasculogenic mimicry in cancer.
    Qiao L; Liang N; Zhang J; Xie J; Liu F; Xu D; Yu X; Tian Y
    J Cell Mol Med; 2015 Feb; 19(2):315-26. PubMed ID: 25598425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.